رجوع
نطاق اليوم
KWD 151.45
KWD 154.69
نطاق 52 أسبوعًا
KWD 101.00
KWD 159.42
حجم التداول
586,573
متوسط 50 يوم / 200 يوم
KWD 134.83
/
KWD 131.28
الإغلاق السابق
KWD 152.21
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Healthcare (627 نظير)
| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | 13.7 | 0.3 |
| P/B | — | 2.9 |
| ROE % | — | 3.7 |
| Net Margin % | 5.5 | 3.8 |
| Rev Growth 5Y % | 4.1 | 10.0 |
| D/E | — | 0.2 |
السعر المستهدف للمحللين
Hold
KWD 168.670
+10.0%
Low: KWD 158.000
High: KWD 190.000
مكرر الربحية المستقبلي
10.8
ربحية السهم المستقبلية
KWD 14.132
نمو ربحية السهم (تقدير)
+0.0%
الإيرادات المقدّرة
14 B
تقديرات الأرباح
| الفترة | تقدير ربحية السهم | تقدير الإيرادات | المحللون |
|---|---|---|---|
| FY2029 |
KWD 18.115
KWD 17.765 – KWD 18.764
|
16 B | 1 |
| FY2028 |
KWD 18.285
KWD 17.932 – KWD 18.940
|
15 B | 1 |
| FY2027 |
KWD 16.272
KWD 16.214 – KWD 16.339
|
14 B | 4 |
النقاط الرئيسية
Revenue grew 4.10% annually over 5 years — modest growth
Earnings declined -20.24% over the past year
Generating 1.31B in free cash flow
P/E of 13.72 — trading at a low valuation
Cash machine — converts 175.50% of earnings into free cash flow
Capital efficient — spends only 4.22% of revenue on capex
النمو
Revenue Growth (5Y)
4.10%
Revenue (1Y)6.46%
Earnings (1Y)-20.24%
FCF Growth (3Y)-6.24%
الجودة
Return on Equity
N/A
ROIC10.47%
Net Margin5.47%
Op. Margin14.74%
الأمان
Debt / Equity
N/A
Current Ratio1.29
Interest Coverage3.66
التقييم
P/E Ratio
13.72
P/B RatioN/A
EV/EBITDA12.20
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 6.46% | Revenue Growth (3Y) | 6.01% |
| Earnings Growth (1Y) | -20.24% | Earnings Growth (3Y) | 3.92% |
| Revenue Growth (5Y) | 4.10% | Earnings Growth (5Y) | -6.53% |
| Profitability | |||
| Revenue (TTM) | 13.64B | Net Income (TTM) | 746.80M |
| ROE | N/A | ROA | 4.27% |
| Gross Margin | 27.00% | Operating Margin | 14.74% |
| Net Margin | 5.47% | Free Cash Flow (TTM) | 1.31B |
| ROIC | 10.47% | FCF Growth (3Y) | -6.24% |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 1.29 |
| Interest Coverage | 3.66 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | 13.72 | P/B Ratio | N/A |
| P/S Ratio | 0.75 | PEG Ratio | -1.11 |
| EV/EBITDA | 12.20 | Dividend Yield | 0.00% |
| Market Cap | 10.25B | Enterprise Value | 24.54B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 13.64B | 12.82B | 12.14B | 11.61B | 11.62B |
| Net Income | 746.80M | 936.34M | 691.54M | 560.40M | 978.45M |
| EPS (Diluted) | 9.51 | 10.73 | 7.42 | 5.71 | 8.90 |
| Gross Profit | 3.68B | 4.22B | 3.82B | 3.40B | 3.65B |
| Operating Income | 2.01B | 2.09B | 1.60B | 1.34B | 1.80B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 17.48B | 17.29B | 16.89B | 16.93B | 17.12B |
| Total Liabilities | 16.32B | 15.19B | 14.15B | 14.70B | 14.75B |
| Shareholders' Equity | -651.08M | 121.12M | 1.06B | 712.33M | 755.51M |
| Total Debt | 15.05B | 12.07B | 11.12B | 11.82B | 11.98B |
| Cash & Equivalents | 757.75M | 794.93M | 380.06M | 244.09M | 461.90M |
| Current Assets | 4.06B | 3.75B | 3.14B | 3.16B | 3.17B |
| Current Liabilities | 3.14B | 2.97B | 2.64B | 2.62B | 2.40B |